BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, July 11, 2026
Breaking News: Ongoing coverage of the Ebola outbreak
Breaking News: AI co-scientist performs biomedical research ‘at expert level’ in less time
Breaking News: Science fiction realized: BCI tech is here
Home
»
Topics
» BioWorld Science, Nephrology
BioWorld Science, Nephrology
RSS
Kissei gains exclusive rights to develop and commercialize avacopan in Japan
June 9, 2017
Vitros NephroCheck test becomes available in Europe
June 9, 2017
Roivant Sciences launches new company
June 8, 2017
Pfizer begins first-in-human study of PF-06730512
June 7, 2017
Palladio Biosciences acquires rights to lixivaptan
May 24, 2017
EMA grants orphan drug designation to avacopan for C3 glomerulopathy
May 24, 2017
Otsuka reports topline results from phase III study of tolvaptan in ADPKD
May 23, 2017
Aurinia initiates phase III study of voclosporin for lupus nephritis
May 18, 2017
Omeros provides update on phase II study of OMS-721
May 18, 2017
FDA grants breakthrough therapy designation to vonapanitase from Proteon Therapeutics
May 11, 2017
Previous
1
2
…
61
62
63
64
65
66
67
68
69
…
329
330
Next
RSS